control strains mu50 Search Results


staphylococcus aureus mrsa mu50 strain  (ATCC)
99
ATCC staphylococcus aureus mrsa mu50 strain
BALB/c mice were infected IP with <t>MRSA</t> (LD100) were treated at 2 hours post-infection with rmLF (100µg/mouse). Survival was monitored post-infection. Control (non-treated) mice succumbed to MRSA infection within 24 hours. Mice treated with rmLF demonstrated increased survival. Data representative of two experimental repeats with 8 mice per experiment.
Staphylococcus Aureus Mrsa Mu50 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+strains+mu50/Staphylococcus/pmc04017373-66-1-6
Average 99 stars, based on 1 article reviews
staphylococcus aureus mrsa mu50 strain - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier
atcc 700699  (ATCC)
96
ATCC atcc 700699
BALB/c mice were infected IP with <t>MRSA</t> (LD100) were treated at 2 hours post-infection with rmLF (100µg/mouse). Survival was monitored post-infection. Control (non-treated) mice succumbed to MRSA infection within 24 hours. Mice treated with rmLF demonstrated increased survival. Data representative of two experimental repeats with 8 mice per experiment.
Atcc 700699, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+strains+mu50/Staphylococcus+aureus%3B+subsp%2E+aureus%3B+Mu50/pmc06831631-67-7-7
Average 96 stars, based on 1 article reviews
atcc 700699 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
control strains  (ATCC)
99
ATCC control strains
BALB/c mice were infected IP with <t>MRSA</t> (LD100) were treated at 2 hours post-infection with rmLF (100µg/mouse). Survival was monitored post-infection. Control (non-treated) mice succumbed to MRSA infection within 24 hours. Mice treated with rmLF demonstrated increased survival. Data representative of two experimental repeats with 8 mice per experiment.
Control Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+strains+mu50/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pmc02691078-79-15-20
Average 99 stars, based on 1 article reviews
control strains - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


BALB/c mice were infected IP with MRSA (LD100) were treated at 2 hours post-infection with rmLF (100µg/mouse). Survival was monitored post-infection. Control (non-treated) mice succumbed to MRSA infection within 24 hours. Mice treated with rmLF demonstrated increased survival. Data representative of two experimental repeats with 8 mice per experiment.

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: BALB/c mice were infected IP with MRSA (LD100) were treated at 2 hours post-infection with rmLF (100µg/mouse). Survival was monitored post-infection. Control (non-treated) mice succumbed to MRSA infection within 24 hours. Mice treated with rmLF demonstrated increased survival. Data representative of two experimental repeats with 8 mice per experiment.

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Infection, Control

BALB/c mice were infected with MRSA (LD100) and treated with 100µg/mouse rmLF at 2 hours post-infection. Blood was collected 1 hour later and colony forming units (CFU) were enumerated. Mice treated with rmLF showed a slight, but non-significant, decrease compared to non-treated controls. Data graphed as mean +/− standard deviation, log scale. Data representative of three experimental repeats with 4–5 mice per experiment.

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: BALB/c mice were infected with MRSA (LD100) and treated with 100µg/mouse rmLF at 2 hours post-infection. Blood was collected 1 hour later and colony forming units (CFU) were enumerated. Mice treated with rmLF showed a slight, but non-significant, decrease compared to non-treated controls. Data graphed as mean +/− standard deviation, log scale. Data representative of three experimental repeats with 4–5 mice per experiment.

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Infection, Standard Deviation

MRSA-infected mice given rmLF as described in Figures 1 and ​and22 demonstrated significant decrease in IL-17, but not IL-6. Data representative of three experimental repeats with at least 5 mice per experiment; rmLF alone did not induce responses above background levels. N=8 depicted with mean +/− standard deviation.

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: MRSA-infected mice given rmLF as described in Figures 1 and ​and22 demonstrated significant decrease in IL-17, but not IL-6. Data representative of three experimental repeats with at least 5 mice per experiment; rmLF alone did not induce responses above background levels. N=8 depicted with mean +/− standard deviation.

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Infection, Standard Deviation

Modulation of pro-inflammatory cytokine production from MRSA-infected mouse splenocytes treated with rmLF.

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: Modulation of pro-inflammatory cytokine production from MRSA-infected mouse splenocytes treated with rmLF.

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques:

TNF-α production from MRSA infected granulocytes after rmouseLF treatment.

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: TNF-α production from MRSA infected granulocytes after rmouseLF treatment.

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Infection

Human blood monocytes isolated from healthy human buffy coats were infected with MRSA (MOI 1:10) and treated with rhLF at 2 hours post-infected were analyzed for cytokine production at 6 hours post-treatment. Addition of rhLF at 100µg/mL increased MRSA-infected PBMC production of IFN-γ and IL-2. rhLF alone did not induce responses above background levels. Data represented as box and whiskers with the box expressing mean, minimum, and maximum, and whiskers as standard deviation. ***=p<0.001

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: Human blood monocytes isolated from healthy human buffy coats were infected with MRSA (MOI 1:10) and treated with rhLF at 2 hours post-infected were analyzed for cytokine production at 6 hours post-treatment. Addition of rhLF at 100µg/mL increased MRSA-infected PBMC production of IFN-γ and IL-2. rhLF alone did not induce responses above background levels. Data represented as box and whiskers with the box expressing mean, minimum, and maximum, and whiskers as standard deviation. ***=p<0.001

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Isolation, Infection, Expressing, Standard Deviation

Human blood monocytes isolated from healthy human buffy coats were infected with MRSA (MOI 1:10) and treated with rhLF at 2 hours postinfected were analyzed for cytokine production at 6 hours post-treatment. Treatment with rhumanLF decreased levels of IL-6, IL-1β, and IL-12p40. A non-significant decrease was also observed in IL-10. *=p<0.05; **=p<0.01; ***=p<0.001

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: Human blood monocytes isolated from healthy human buffy coats were infected with MRSA (MOI 1:10) and treated with rhLF at 2 hours postinfected were analyzed for cytokine production at 6 hours post-treatment. Treatment with rhumanLF decreased levels of IL-6, IL-1β, and IL-12p40. A non-significant decrease was also observed in IL-10. *=p<0.05; **=p<0.01; ***=p<0.001

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Isolation, Infection

Granulocytes isolated from human buffy coats were infected with MRSA (MOI 1:10) and treated with rhLF at 2 hours post-infection. Supernatants were collected and analyzed by ELISA at 6 hours post-treatment. While there was no change in TNF-α, addition of rhLF led to an increase in IL-1β production from MRSA-infected granulocytes. Data represented as box and whiskers with the box expressing mean, minimum, and maximum, and whiskers as standard deviation. *=p<0.05

Journal: International immunopharmacology

Article Title: Immunomodulatory effects of recombinant lactoferrin during MRSA infection

doi: 10.1016/j.intimp.2014.02.029

Figure Lengend Snippet: Granulocytes isolated from human buffy coats were infected with MRSA (MOI 1:10) and treated with rhLF at 2 hours post-infection. Supernatants were collected and analyzed by ELISA at 6 hours post-treatment. While there was no change in TNF-α, addition of rhLF led to an increase in IL-1β production from MRSA-infected granulocytes. Data represented as box and whiskers with the box expressing mean, minimum, and maximum, and whiskers as standard deviation. *=p<0.05

Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) Mu50 strain (ATCC) with intermediate vancomycin resistance was grown in BBLTM Muller-Hinton (MH) (Becton, Dickinson and Company) broth supplemented with 4μg/mL of Vancomycin (according to Sigma protocols) at 37°C and rotating at 225rpm.

Techniques: Isolation, Infection, Enzyme-linked Immunosorbent Assay, Expressing, Standard Deviation